Literature DB >> 2536195

Repression of the IgH enhancer in teratocarcinoma cells associated with a novel octamer factor.

M J Lenardo1, L Staudt, P Robbins, A Kuang, R C Mulligan, D Baltimore.   

Abstract

Embryonal carcinoma (EC) cell lines are models for early cells in mouse embryogenesis. A 300-base pair fragment of the heavy chain enhancer was inactive in F9 EC cells, unlike in other nonlymphoid cells where it has significant activity. Alterations of the octamer motif increased enhancer activity. Nuclear extracts from F9 cells contained an octamer binding protein (NF-A3) that was unique to EC cells; the amount of NF-A3 decreased upon differentiation. It is proposed that NF-A3 represses specific regulatory sequences that contain the octamer motif. Thus, the same DNA sequence mediates either negative or positive transcriptional effects, depending on the cell type.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536195     DOI: 10.1126/science.2536195

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  60 in total

1.  Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells.

Authors:  Hitoshi Niwa; Shinji Masui; Ian Chambers; Austin G Smith; Jun-ichi Miyazaki
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

2.  Repression of human cytomegalovirus gene expression associated with a novel immediate early regulatory region binding factor.

Authors:  S L Shelbourn; S K Kothari; J G Sissons; J H Sinclair
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

3.  A DNA element that regulates expression of an endogenous retrovirus during F9 cell differentiation is E1A dependent.

Authors:  B T Lamb; K Satyamoorthy; D Solter; A Basu; M Q Xu; R Weinmann; C C Howe
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

4.  Circadian oscillations in period gene mRNA levels are transcriptionally regulated.

Authors:  P E Hardin; J C Hall; M Rosbash
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

5.  Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins.

Authors:  E Schreiber; K Harshman; I Kemler; U Malipiero; W Schaffner; A Fontana
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

6.  The B-cell and neuronal forms of the octamer-binding protein Oct-2 differ in DNA-binding specificity and functional activity.

Authors:  C L Dent; K A Lillycrop; J K Estridge; N S Thomas; D S Latchman
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

7.  Negative regulation of the major histocompatibility complex class I promoter in embryonal carcinoma cells.

Authors:  J R Flanagan; M Murata; P A Burke; Y Shirayoshi; E Appella; P A Sharp; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

8.  Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression.

Authors:  T A Libermann; M Lenardo; D Baltimore
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

9.  The importance of the 3'-enhancer region in immunoglobulin kappa gene expression.

Authors:  K B Meyer; M J Sharpe; M A Surani; M S Neuberger
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

10.  Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer.

Authors:  L Dailey; H Yuan; C Basilico
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.